This is an editorial summary of research originally reported by . ProductSafer does not claim ownership of the underlying research. All intellectual property belongs to the original publishers.
Free weekly digest
We track health and safety research on food, cosmetics, and household products and send you what matters. Join 27 readers.
What would you like to do next?
I use this product
Get the next safety alert before it goes viral
Free weekly digest of health findings about everyday products. No spam, unsubscribe any time.
Advertisement
Get the latest health findings delivered to your inbox. Only the important stuff. No spam.
We'll send a confirmation email. Unsubscribe anytime.
The global community set a goal to end AIDS as a public health threat by 2030, and progress has been substantial with new HIV infections and deaths declining by nearly 60% in the hardest-hit regions since 2010. More than 77% of people living with HIV now receive antiretroviral therapy, showing that treatment access is improving worldwide. Continued momentum on these fronts is critical to meeting the 2030 targets and building a world without AIDS.
# Editorial Summary
The global health community set an ambitious target a decade ago: eliminate AIDS as a public health threat by 2030 by cutting new HIV infections and AIDS-related deaths by 90% compared to 2010 levels. While this goal remains challenging, progress has been measurable and encouraging. Eastern and southern Africa, the regions most heavily impacted by HIV, have seen particularly significant improvements, with new infections and deaths each dropping by roughly 60% over the past 14 years. These gains demonstrate that coordinated international effort and investment in treatment can produce real results.
A major milestone has been the expansion of antiretroviral therapy (ART), the medications that allow people with HIV to live long, healthy lives and prevent transmission to others. As of 2024, more than three-quarters of people living with HIV globally are receiving this treatment. This widespread access to effective drugs represents a dramatic shift from earlier decades and has been crucial to reducing both deaths and new infections. However, the article suggests that some regions and populations still face barriers to accessing these life-saving treatments, indicating that work remains to close gaps in care.
The pathway to 2030 and beyond requires sustained commitment to increasing treatment access, improving prevention strategies, and ensuring that gains are maintained across all regions and communities. The data shows that when resources and political will align, meaningful progress is possible, but the global community must continue building on this foundation to reach the original targets and ultimately end the epidemic.
What consumers can do: If you're living with HIV or at risk, discuss prevention and treatment options with a healthcare provider. Support for accessible treatment programs and public health initiatives remains critical, and staying informed about HIV prevention methods, including PrEP (pre-exposure prophylaxis) for those at high risk, can help protect your health.
Always consult a healthcare professional for personal medical advice.
Read the full report at the original source
The LancetWas this finding useful?
Community discussion
Join the discussion
Comments are reviewed before appearing publicly.